ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,406.70
0.57%
S&P ASX All Technology
3,915.30
0.60%
Brent Oil
72.68
0.32%
US Dollar vs AUD
1.54462
0.00%
Bitcoin
93,425.63
1.58%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Voyager Therapeutics Inc (VYGR)

  7. Voyager Therapeutics Inc (VYGR) News

VYGR

Voyager Therapeutics (VYGR)

Voyager Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VYGR
DateTimeSourceHeadlineSymbolCompany
20/11/202423:00GlobeNewswire Inc.Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer’s DiseaseNASDAQ:VYGRVoyager Therapeutics Inc
13/11/202408:01GlobeNewswire Inc.Voyager Reports Third Quarter 2024 Financial and Operating ResultsNASDAQ:VYGRVoyager Therapeutics Inc
13/11/202408:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VYGRVoyager Therapeutics Inc
06/11/202423:00GlobeNewswire Inc.Voyager Therapeutics to Present at Multiple Upcoming Investor ConferencesNASDAQ:VYGRVoyager Therapeutics Inc
05/11/202423:00GlobeNewswire Inc.Voyager Therapeutics Announces Third Quarter 2024 Conference Call and WebcastNASDAQ:VYGRVoyager Therapeutics Inc
04/10/202406:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
03/10/202406:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
03/10/202406:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
16/09/202421:00GlobeNewswire Inc.Voyager Advances Collaboration with Neurocrine; Third Gene Therapy Development Candidate SelectedNASDAQ:VYGRVoyager Therapeutics Inc
05/09/202422:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VYGRVoyager Therapeutics Inc
05/09/202422:00GlobeNewswire Inc.Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14NASDAQ:VYGRVoyager Therapeutics Inc
30/08/202406:01GlobeNewswire Inc.Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VYGRVoyager Therapeutics Inc
29/08/202421:00GlobeNewswire Inc.Voyager Therapeutics to Present at Multiple Upcoming Investor ConferencesNASDAQ:VYGRVoyager Therapeutics Inc
07/08/202421:00GlobeNewswire Inc.Voyager Therapeutics to Present at Canaccord Genuity 44th Annual Growth Conference & Private Company ShowcaseNASDAQ:VYGRVoyager Therapeutics Inc
07/08/202406:11Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VYGRVoyager Therapeutics Inc
07/08/202406:01GlobeNewswire Inc.Voyager Therapeutics Reports Second Quarter 2024 Financial and Operating ResultsNASDAQ:VYGRVoyager Therapeutics Inc
07/08/202406:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VYGRVoyager Therapeutics Inc
30/07/202421:00GlobeNewswire Inc.Voyager Therapeutics Announces Second Quarter 2024 Conference Call and WebcastNASDAQ:VYGRVoyager Therapeutics Inc
24/07/202406:01GlobeNewswire Inc.Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VYGRVoyager Therapeutics Inc
10/07/202406:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
10/07/202406:10Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
10/07/202406:01GlobeNewswire Inc.Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VYGRVoyager Therapeutics Inc
14/06/202406:01GlobeNewswire Inc.Voyager Therapeutics to Present at Multiple Virtual Investor ConferencesNASDAQ:VYGRVoyager Therapeutics Inc
13/06/202421:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VYGRVoyager Therapeutics Inc
13/06/202421:00GlobeNewswire Inc.Voyager Therapeutics Announces Appointment of Nathan Jorgensen as Chief Financial OfficerNASDAQ:VYGRVoyager Therapeutics Inc
08/06/202406:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
08/06/202406:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
08/06/202406:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
08/06/202406:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
08/06/202406:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:VYGR

Your Recent History

ASX
XTO
S&P ASX 100
ASX
SUN
Suncorp
PM
XAUUSD
Gold vs US Dollar
ASX
CSL
CSL
NYSE
DIS
Walt Disney
NASDAQ
AMZN
Amazon.com
NYSE
NKE
Nike
NYSE
MRK
Merck
ASX
XAO
Australian SE All Ordina...
ASX
XFL
S&P ASX 50
FX
GBPAUD
Sterling vs AUD
ASX
XMM
S&P ASX 300 Metals and M...
NYSE
MCD
McDonalds
COIN
ETHUSD
Ethereum
ASX
WOW
Woolworths
COIN
AVAXUSD
Avalanche
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for ASX Level 1 & 2

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $1958.40 only $783.36